Early p53 alterations in mouse skin carcinogenesis by UVB radiation: immunohistochemical detection of mutant p53 protein in clusters of preneoplastic epidermal cells

R J Berg, H J van Kranen, H G Rebel, A de Vries, W A van Vloten, C F Van Kreijl, J C van der Leun, F R de Gruijl, R J Berg, H J van Kranen, H G Rebel, A de Vries, W A van Vloten, C F Van Kreijl, J C van der Leun, F R de Gruijl

Abstract

High levels of the p53 protein are immunohistochemically detectable in a majority of human nonmelanoma skin cancers and UVB-induced murine skin tumors. These increased protein levels are often associated with mutations in the conserved domains of the p53 gene. To investigate the timing of the p53 alterations in the process of UVB carcinogenesis, we used a well defined murine model (SKH:HR1 hairless mice) in which the time that tumors appear is predictable from the UVB exposures. The mice were subjected to a series of daily UVB exposures, either for 17 days or for 30 days, which would cause skin tumors to appear around 80 or 30 weeks, respectively. In the epidermis of these mice, we detected clusters of cells showing a strong immunostaining of the p53 protein, as measured with the CM-5 polyclonal antiserum. This cannot be explained by transient accumulation of the normal p53 protein as a physiological response to UVB-induced DNA damage. In single exposure experiments the observed transient CM-5 immunoreactivity lasted for only 3 days and was not clustered, whereas these clusters were still detectable as long as 56 days after 17 days of UVB exposure. In addition, approximately 70% of these patches reacted with the mutant-specific monoclonal antibody PAb240, whereas transiently induced p53-positive cells did not. In line with indicative human data, these experimental results in the hairless mouse model unambiguously demonstrate that constitutive p53 alterations are causally related to chronic UVB exposure and that they are a very early event in the induction of skin cancer by UVB radiation.

References

    1. Nature. 1994 Dec 22-29;372(6508):773-6
    1. Nature. 1992 Jul 2;358(6381):15-6
    1. Carcinogenesis. 1995 May;16(5):1141-7
    1. J Invest Dermatol. 1995 Jun;104(6):928-32
    1. J Histochem Cytochem. 1987 Nov;35(11):1343-5
    1. Cancer Res. 1993 Jan 1;53(1):53-60
    1. Oncogene. 1993 Jan;8(1):203-7
    1. Proc Natl Acad Sci U S A. 1993 May 1;90(9):4216-20
    1. Cell. 1993 Sep 10;74(5):813-22
    1. Cell. 1993 Nov 19;75(4):765-78
    1. Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):360-4
    1. Cancer Res. 1994 Sep 15;54(18):4855-78
    1. J Pathol. 1994 Jan;172(1):1-4
    1. Photochem Photobiol. 1983 Jan;37(1):53-62
    1. Bioessays. 1995 Jul;17(7):651-60
    1. EMBO J. 1990 May;9(5):1595-602
    1. Oncogene. 1990 Jul;5(7):945-52
    1. Cancer Res. 1991 Feb 1;51(3):979-84
    1. Nature. 1991 Jul 25;352(6333):345-7
    1. Cancer Res. 1991 Dec 1;51(23 Pt 1):6304-11
    1. Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10124-8
    1. J Mol Biol. 1992 Jun 5;225(3):577-83
    1. Oncogene. 1995 Jan 19;10(2):389-93

Source: PubMed

3
購読する